✦ LIBER ✦

A model for ultrafilterable plasma platinum disposition in patients treated with cisplatin

✍ Scribed by Phillip A. Reece; Irene Stafford; Jack Russell; Miriam Khan; P. Grantley Gill

Publisher: Springer
Year: 1987
Tongue: English
Weight: 601 KB
Volume: 20
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00252955

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A modified pharmacokinetic model for pla

A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatin

✍ H. Griffiths; M. D. Shelley; R. G. Fish 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 546 KB

Tumoral platinum concentrations in patie

Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer

✍ Jean-Léon Lagrange; Pierre-Yves Bondiau; Eric Tessier; Pierre Chauvel; Nicole Re 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 485 KB 👁 2 views

The aim of the present study was to check whether platinum (Pt) concentrations achieved in tumors with a daily low-dose schedule were close to those promoting radiosensitization. Fifteen previously untreated patients with histologically proven advanced uterine cervix tumors were studied. They receiv

Distribution of platinum in patients tre

Distribution of platinum in patients treated with cisplatin determined by radiochemical neutron activation analysis

✍ K. Heydorn; B. Rietz; A. Krarup-Hansen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Cisplatin is used in a successful treatment of testicular cancer and some related conditions, but several toxic effects have been observed. Knowledge about the distribution of platinum in the human body after treatment with massive doses of cisplatin might provide clues to the origin of side effects

Retrobulbar neuritis in a patient treate

Retrobulbar neuritis in a patient treated with intraarterial cisplatin for head and neck cancer

✍ Susan Urba; Arlene A. Forastiere 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Inductively coupled plasma mass spectrom

Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin

✍ E. E. M. Brouwers; M. M. Tibben; D. Pluim; H. Rosing; H. Boot; A. Cats; J. H. M. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 205 KB

Pretreatment prognostic factors for surv

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

✍ Joaquim Bellmunt; Joan Albanell; Luis Paz-Ares; Miguel A. Climent; Jose L. Gonzá 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Background: New chemotherapeutic agents, including paclitaxel and gemcitabine, are active in advanced bladder carcinoma, and combination regimens with these agents have shown promising results. unlike conventional chemotherapy regimens, such as methotrexate, vinblastine, doxorubicin, and cisplat